The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice
The Journal of pathology, 2020-04, Vol.250 (5), p.667 [Peer Reviewed Journal]2020 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. ;EISSN: 1096-9896 ;DOI: 10.1002/path.5406 ;PMID: 32129476
Digital Resources/Online E-Resources
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||